NEW YORK, Aug. 1, 2022 /PRNewswire/ -- The animal wound care market will be driven by factors such as the dependency on livestock products. The demand for livestock products is increasing across the world, with the growing population. Hence, governments and vendors are focusing on food safety to prevent the transfer of diseases to humans. Proper animal wound care helps in maintaining food safety. The economic impact of livestock diseases is also high, as it directly affects product supply and leads to other indirect losses to the people dependent on these products as an income source. In addition, livestock products are used in the leather, fiber, draft power and transportation, and fertilizer industries. Hence, the increasing dependency on livestock products will support the growth of the global animal wound care market during the forecast period.
The "Animal Wound Care Market by Application (surgical wound care and traditional wound care) and Geography (North America, Europe, APAC, and South America) - Forecast and Analysis 2020-2024" report has been added to Technavio's offering. The potential growth difference for the animal wound care market size between 2019 and 2024 is USD 661.63 million.
To get the exact CAGR of the animal wound care market and the Y-O-Y growth rate, Request a Sample Report
The rising pet care expenditure is challenging the growth of the market, as prospective pet owners may be hesitant to adopt pets. Healthcare costs for pets have increased significantly in the last few years. Moreover, strict government norms regarding animal and environmental safety increase the economic burden on pet owners.
Technavio's report provides a list of challenges that can help companies prepare for future market scenarios. View our Sample Report
The animal wound care market report is segmented by application (surgical wound care and traditional wound care) and geography (North America, Europe, APAC, and South America).
By application, the surgical wound care segment will contribute the highest market share growth during the forecast period. This growth is attributed to factors such as the high adoption of products in hospitals and clinics for wound healing and the rising adoption of pets globally.
By geography, North America will be the leading region with 34% of the market's growth during the forecast period. The US is a key country for the animal wound care market in the region. Moreover, market growth in this region will be faster than the growth of the market in other regions. Vendors are acquiring new facilities to synergize their R&D capabilities, owing to the high demand for animal wound care. This is driving the growth of the market in North America.
Learn about the contribution of each segment of the animal wound care market, summarized in concise infographics and thorough descriptions. View a Sample Report
- 3M Co.
- B. Braun Melsungen AG
- Biogenesis Bago SA
- Ceva Sante Animale
- Indian Immunologicals Ltd.
- Johnson & Johnson
- Medtronic Plc
- Phibro Animal Health Corp.
- Vetoquinol SA
- Virbac Group
Want your report customized? Speak to an analyst and personalize your report according to your needs.
Animal Sedative Market by Type and Geography - Forecast and Analysis 2022-2026
Animal Healthcare Market by Product and Geography - Forecast and Analysis 2021-2025
Animal Wound Care Market Scope | |
Report Coverage | Details |
Page number | 120 |
Base year | 2019 |
Forecast period | 2020-2024 |
Growth momentum & CAGR | Accelerate at a CAGR of 6.44% |
Market growth 2020-2024 | USD 661.63 million |
Market structure | Fragmented |
YoY growth (%) | 6.01 |
Regional analysis | North America, Europe, APAC, and South America |
Performing market contribution | North America at 34% |
Key consumer countries | US, UK, China, Germany, and France |
Competitive landscape | Leading companies, competitive strategies, consumer engagement scope |
Companies profiled | 3M Co., B. Braun Melsungen AG, Biogenesis Bago SA, Ceva Sante Animale, Indian Immunologicals Ltd., Johnson & Johnson, Medtronic Plc, Phibro Animal Health Corp., Vetoquinol SA, and Virbac Group |
Market Dynamics | Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Key Topics Covered:
1. Executive Summary
2. Market Landscape
2.1 Market ecosystem
2.1.1 Parent market
Exhibit 01: Parent market
Exhibit 02: Market characteristics
2.2 Value chain analysis
Exhibit 03: Value chain analysis for pharmaceuticals
2.2.1 Research and development (R&D) and drug discovery
2.2.2 Integration and product development
2.2.3 Manufacturing
2.2.4 Outbound logistics
2.2.5 Marketing and sales
2.2.6 Support services
2.2.7 Innovation
3. Market Sizing
3.1 Market definition
Exhibit 04: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 05: Market segments
3.3 Market size 2020
3.4 Market outlook: Forecast for 2020 - 2025
Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)
4. Five Forces Analysis
4.1 Five Forces Summary
Exhibit 08: Five forces analysis 2020 & 2025
4.2 Bargaining power of buyers
Exhibit 09: Bargaining power of buyers
4.3 Bargaining power of suppliers
Exhibit 10: Bargaining power of suppliers
4.4 Threat of new entrants
Exhibit 11: Threat of new entrants
4.5 Threat of substitutes
Exhibit 12: Threat of substitutes
4.6 Threat of rivalry
Exhibit 13: Threat of rivalry
4.7 Market condition
Exhibit 14: Market condition - Five forces 2020
5. Market Segmentation by Application
5.1 Market segments
Exhibit 15: Application - Market share 2020-2025 (%)
5.2 Comparison by Application
Exhibit 16: Comparison by Application
5.3 Surgical wound care - Market size and forecast 2020-2025
Exhibit 17: Surgical wound care - Market size and forecast 2020-2025 ($ million
Exhibit 18: Surgical wound care - Year-over-year growth 2020-2025 (%)
5.4 Traditional wound care - Market size and forecast 2020-2025
Exhibit 19: Traditional wound care - Market size and forecast 2020-2025 ($ million)
Exhibit 20: Traditional wound care - Year-over-year growth 2020-2025 (%)
5.5 Market opportunity by Application
Exhibit 21: Market opportunity by Application
6. Customer landscape
6.1 Overview
Technavio's customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
Exhibit 22: Customer landscape
7. Geographic Landscape
7.1 Geographic segmentation
Exhibit 23: Market share by geography 2020-2025 (%)
7.2 Geographic comparison
Exhibit 24: Geographic comparison
7.3 North America - Market size and forecast 2020-2025
Exhibit 25: North America - Market size and forecast 2020-2025 ($ million)
Exhibit 26: North America - Year-over-year growth 2020-2025 (%)
7.4 Europe - Market size and forecast 2020-2025
Exhibit 27: Europe - Market size and forecast 2020-2025 ($ million)
Exhibit 28: Europe - Year-over-year growth 2020-2025 (%)
7.5 Asia - Market size and forecast 2020-2025
Exhibit 29: Asia - Market size and forecast 2020-2025 ($ million
Exhibit 30: Asia - Year-over-year growth 2020-2025 (%)
7.6 ROW - Market size and forecast 2020-2025
Exhibit 31: ROW - Market size and forecast 2020-2025 ($ million)
Exhibit 32: ROW - Year-over-year growth 2020-2025 (%)
7.7 Key leading countries
Exhibit 33: Key leading countries
7.8 Market opportunity by geography
Exhibit 34: Market opportunity by geography ($ million)
8. Drivers, Challenges, and Trends
8.1 Market drivers
8.1.1 Dependency on livestock products
8.1.2 Technological advancements in animal wound care industr
8.1.3 Increase in pet ownership
8.2 Market challenges
8.2.1 Rising pet care expenditure
8.2.2 Increasing population of stray animals in developing countries
8.2.3 Lack of government funding and trained professionals
Exhibit 35: Impact of drivers and challenges
8.3 Market trends
8.3.1 Growing innovations in animal wound dressing techniques
8.3.2 Rising awareness about pet insurance
8.3.3 Increase in investments
9. Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 36: Vendor landscape
9.3 Landscape disruption
Exhibit 37: Landscape disruption
Exhibit 38: Industry risks
10. Vendor Analysis
10.1 Vendors covered
Exhibit 39: Vendors covered
10.2 Market positioning of vendors
Exhibit 40: Market positioning of vendors
10.3 3M Co.
Exhibit 41: 3M Co. - Overview
Exhibit 42: 3M Co. - Business segments
Exhibit 43: 3M Co. – Key news
Exhibit 44: 3M Co. - Key offerings
Exhibit 45: 3M Co. - Segment focus
10.4 B. Braun Melsungen AG
Exhibit 46: B. Braun Melsungen AG - Overview
Exhibit 47: B. Braun Melsungen AG - Business segments
Exhibit 48: B. Braun Melsungen AG – Key news
Exhibit 49: B. Braun Melsungen AG - Key offerings
Exhibit 50: B. Braun Melsungen AG - Segment focus
10.5 Biogenesis Bago SA
Exhibit 51: Biogenesis Bago SA - Overview
Exhibit 52: Biogenesis Bago SA - Product and service
Exhibit 53: Biogenesis Bago SA - Key offerings
10.6 Innovacyn Inc.
Exhibit 54: Innovacyn Inc. - Overview
Exhibit 55: Innovacyn Inc. - Product and service
Exhibit 56: Innovacyn Inc. - Key offerings
10.7 Johnson & Johnson
Exhibit 57: Johnson & Johnson - Overview
Exhibit 58: Johnson & Johnson - Business segments
Exhibit 59: Johnson & Johnson – Key news
Exhibit 60: Johnson & Johnson - Key offerings
Exhibit 61: Johnson & Johnson - Segment focus
10.8 Jorgen Kruuse AS
Exhibit 62: Jorgen Kruuse AS - Overview
Exhibit 63: Jorgen Kruuse AS - Product and service
Exhibit 64: Jorgen Kruuse AS - Key offerings
10.9 Medtronic Plc
Exhibit 65: Medtronic Plc - Overview
Exhibit 66: Medtronic Plc - Business segments
Exhibit 67: Medtronic Plc – Key news
Exhibit 68: Medtronic Plc - Key offerings
Exhibit 69: Medtronic Plc - Segment focus
10.10 Neogen Corp.
Exhibit 70: Neogen Corp. - Overview
Exhibit 71: Neogen Corp. - Business segments
Exhibit 72: Neogen Corp. - Key offerings
Exhibit 73: Neogen Corp. - Segment focus
10.11 Vetoquinol SA
Exhibit 74: Vetoquinol SA - Overview
Exhibit 75: Vetoquinol SA - Business segments
Exhibit 76: Vetoquinol SA – Key news
Exhibit 77: Vetoquinol SA - Key offerings
Exhibit 78: Vetoquinol SA - Segment focus
10.12 Virbac
Exhibit 79: Virbac - Business segments
Exhibit 80: Virbac – Key news
Exhibit 81: Virbac - Key offerings
Exhibit 82: Virbac - Segment focus
11. Appendix
11.1 Scope of the report
11.1.1 Market definition
11.1.2 Objectives
11.1.3 Notes and caveats
11.2 Currency conversion rates for US$
Exhibit 83: Currency conversion rates for US$
11.3 Research methodology
Exhibit 84: Research Methodology
Exhibit 85: Validation techniques employed for market sizing
Exhibit 86: Information sources
11.4 List of abbreviations
Exhibit 87: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:media@technavio.com
Website: www.technavio.com/
SOURCE Technavio
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
